KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Times Interest Earned (2020 - 2025)

Alnylam Pharmaceuticals' Times Interest Earned history spans 6 years, with the latest figure at $2.01 for Q4 2025.

  • For Q4 2025, Times Interest Earned rose 174.64% year-over-year to $2.01; the TTM value through Dec 2025 reached $2.41, up 293.06%, while the annual FY2025 figure was $1.99, 259.23% up from the prior year.
  • Times Interest Earned reached $2.01 in Q4 2025 per ALNY's latest filing, down from $8.29 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $8.29 in Q3 2025 to a low of -$7.65 in Q2 2023.
  • Average Times Interest Earned over 5 years is -$2.23, with a median of -$3.59 recorded in 2022.
  • Peak YoY movement for Times Interest Earned: plummeted 132.32% in 2024, then soared 470.48% in 2025.
  • A 5-year view of Times Interest Earned shows it stood at -$5.28 in 2021, then fell by 19.31% to -$6.31 in 2022, then surged by 41.09% to -$3.71 in 2023, then rose by 27.35% to -$2.7 in 2024, then surged by 174.64% to $2.01 in 2025.
  • Per Business Quant, the three most recent readings for ALNY's Times Interest Earned are $2.01 (Q4 2025), $8.29 (Q3 2025), and -$0.4 (Q2 2025).